The table below shows highlighted markets in the MENA region, and their performance in 2013. Saudi Arabia is the largest pharma market in the region, with Iraq as the fastest growing market.
written on 07.10.2014
MENA – Pharma Sales & Market Growth, 2013
Similar Facts and Figures
Egyptian Pharma Market Snapshot
The Egyptian pharma market grew at a compound annual growth rate (CAGR) of 17 percent between 2011 and 2017 to reach a total market valuation of EGP 50 billion in…
Pharmaceuticals – Egypt’s Top Performing Sector
The following chart shows the relative performance of the Egyptian economy by sector and highlights the importance of healthcare and pharmaceuticals as Egypt’s top performing sector. Click here to read…
Pharmaceuticals – Egypt's Top Performing Sector
The following chart shows the relative performance of the Egyptian economy by sector and highlights the importance of healthcare and pharmaceuticals as Egypt’s top performing sector. Click here to read…
Egyptian Healthcare by Numbers
The following chart provides information on Egyptian healthcare spending, pharma consumption, local production and employment. Click here to read more articles and interviews from Egypt, and to download the latest…
Top 20 Pharma Companies in Egypt 2018
The Top 20 Pharma Companies in Egypt for 2018, ranked by sales value. Big Pharma makes up the Top Three positions in the shape of Novartis, GSK and Sanofi, followed…
Leadership / What’s on the Mind of Amgen Execs?
Amgen has forged a solid position as one of the world’s largest independent biotechnology companies. With a market capitalisation of some USD 130 billion and 27 approved medicines, the US-based…
Leadership / What’s on AbbVie Regional and Country Managers' Minds?
There have been both ups and downs in AbbVie’s recent history. After proving its staying power with the celebration of its 10-year anniversary as an independent company spun off from…
Leadership / What’s on the Mind of GSK Country Managers?
GSK has undergone a number of changes in recent years. After driving a major transformation that began in 2017 to strengthen its R&D performance, the British multinational suffered the impact…